Broadcom shares fell more than 11% on Friday after the chipmaker warned growing sales of lower-margin custom AI processors ...
Broadcom stock plunges as lower-margin AI revenue pressures profitability despite strong earnings and a record $73B backlog.
Apellis Pharmaceuticals, Inc. faces a Sell rating amid revenue stagnation, Syfovre challenges, and uncertain long-term profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback